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Abstract The membrane bound matrix metalloproteinase
MT1-MMP plays roles in modulating cell movement, independent of its abilities to remodel the extracellular matrix.
Unlike many MMPs, MT1-MMP is activated in the Golgi
prior to secretion by a pro-protein convertase, primarily furin.
Regulation of the activation of pro-MT1-MMP has been methodically investigated, as altering the level of the active protein has broad implications in both activating other proMMPs, including pro-MMP-2, and many subsequent remodelling events. Our previous work in MCF-7 cells has demonstrated that modest, and not extremely high, levels of active
MT1-MMP manifests into altered cell morphology and movement. At this low but optimal amount of MT1-MMP protein,
changes to MT1-MMP levels are always mirrored by MMP-9
and pERK levels, and always opposite to MMP-2 levels. In
this study, stable expression of the furin inhibitor α1antitrypsin Portland (α1-PDX) in MDA-MB-231 cells increased overall MT1-MMP levels, but cells maintained a
21% proportion of pro-MT1-MMP. The increase in MT1MMP was mirrored by increases in MMP-9 and pERK, but
a decrease in MMP-2. These changes were associated with
increased NF-κB transcription. In vitro analysis showed that

α1-PDX decreased cell protrusions and migration, and this
manifested as decreased tumourigenesis when examined
in vivo using a chick CAM assay.

J. A. Willson, C. A. Muir and C. L. Evered contributed equally to this
work.

Introduction

* S. Damjanovski
sdamjano@uwo.ca

Matrix metalloproteinases (MMPs) are a family of zincdependent endopeptidases which function collectively to
cleave all components of the extracellular matrix (ECM)
(Bourboulia and Stetler-Stevenson 2010). To maintain tissue
integrity, the correct MMP family member must be present in
its appropriate form (inactive, inhibited, or active) at the proper time and location (Egeblad and Werb 2002; Ellis and
Crawford 2016; Nieuwesteeg et al. 2012, Walsh et al. 2012).
Retaining proper MMP activity in tissues is achieved through
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regulation of MMP expression, pro-enzyme activation, and
enzymatic activity through catalytic inhibition by their endogenous inhibitors, TIMPs and RECK (Visse and Nagase 2003).
MMPs share common structural domains, including a catalytic domain and a pro-domain whose removal is needed for
MMP activation. MT-MMPs also contain a transmembrane
domain and a C-terminal cytoplasmic tail that is essential for
localization and recycling (Seiki, 2003; Strongin, 2010).
Unlike secreted MMPs, which are activated extracellularly,
MT-MMPs are activated intracellularly in the trans-Golgi by
a protein-convertase-dependent mechanism (Sternlicht and
Werb 2001). Membrane type-1 matrix metalloproteinase
(MT1-MMP, MMP-14) is a multifunctional cell-surface molecule whose functions extend beyond its classification as a
protease (Egeblad and Werb 2002). The pro-domain of
MT1-MMP contains a furin cleavage motif, with trans-Golgi
localized furin being a key component in its activation
(Scamuffa et al. 2006; Seidah et al. 2008).
Once active as a proteolytic enzyme, MT1-MMP is directly
involved in the pericellular cleavage of several ECM glycoproteins and cell surface proteins. MT1-MMP proteolysis also
activates other secreted pro-MMPs, most notably the
gelatinases pro-MMP-2 and -9 (Toth et al. 2003).
Independent of proteolysis, the functions of MT1-MMP include activating intracellular signalling cascades, such as the
MAPK pathway, resulting in changes in cell behaviour and
function (Cepeda et al. 2016; Cepeda et al. 2017a; Pahwa et al.
2014).
Taken together, the invasive potential of MT1-MMPexpressing cells is manifested by its degradation of ECM, its
activation of the powerful gelatinase pro-MMP-2, and by signalling cascades (Itoh et al. 2001). Paradoxically, during the
activation of pro-MMP-2, two MT1-MMP molecules act with
an inhibitory TIMP-2 molecule. This MT1-MMP/TIMP-2/
pro-MMP-2 complex principally activates pro-MMP-2, but
has also been shown to activate secreted pro-MMP-9 (Toth
et al. 2003). Further, MT1-MMP and TIMP-2 form an additional complex that initiates the intracellular cascade of the
MAPK pathway, leading to downstream phosphorylation of
Extracellular-Signal-Regulated Kinase (ERK1/2) (Sounni
et al. 2010). Additionally, we recently showed that altering
MT1-MMP activation, MMP catalytic activity, and ERK1/2
signalling (using furin inhibitor, BB94, and U0126, respectively) in MCF-7 and MDA-MB-231 cells resulted in inverse
MMP-2 and -9 levels, regardless of treatment (Cepeda et al.
2017a). This association was dependent on the cytoplasmic
domain of MT1-MMP, where elevated levels of active MT1MMP were mirrored by elevated pERK and MMP-9 levels,
but lower MMP-2 levels, and resulted in cells that were more
tumourigenic (Cepeda et al. 2017b).
The effect of inhibiting MT1-MMP activation using furin
inhibitors, including α1-antitrypsin Portland (Jean et al.
1998), has been examined in various cancer cell lines.
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However, the resulting effects on MT1-MMP levels, cell migration, and invasiveness have been confounding. In primary
colorectal cancer cells, expression of α1-PDX increased
pERK levels and cell migration, independent of MT1-MMP
levels (Defilles et al. 2011). In HeLa and osteosarcoma cells,
α1-PDX reduced global MT1-MMP protein levels and decreased migration. However, neither study differentiated between the levels of the pro- nor active forms of MT1-MMP
(Liu et al. 2014; Shi et al. 2015). Bassi et al. (2001) also
showed a decrease in invasiveness using three head and neck
squamous cell carcinoma cell lines, however, the α1-PDXtransfected cells showed an increase in the amount of both
pro- and active MT1-MMP protein levels. This increase in
both active and pro-MT1-MMP was also observed in COS1, HT-1080, and LoVo cells that were transfected with α1PDX (Yana and Weiss 2000). In vivo work has also demonstrated that α1-PDX can enhance the expression and activity
of MT1-MMP in mouse joints (Lin et al. 2012), despite α1PDX’s known role as a furin inhibitor that should lower active
MT1-MMP levels.
To investigate inconsistent α1-PDX data and build on our
previous findings where elevated MT1-MMP levels, together
with elevated pERK and MMP-9 levels, increased tumour
progression, here we examine the effect of stable expression
of α1-PDX in MDA-MB-231 cells. To our knowledge, the
effect of α1-PDX has never been examined through stable
transfection in MDA-MB-231 cells. Similar to our previous
findings, we show here that elevated active levels of MT1MMP were associated with elevated pERK and MMP-9
levels, but decreased MMP-2 levels. However, these changes
were associated with lower levels of NF-κB transcription and
reduced in vitro cell migration/invasion, as well as reduced
in vivo tumourigenesis in a chick chorioallantoic membrane
(CAM) assay.

Materials and methods
Cell culture conditions and generation of stable cell lines
The human breast cancer cell line MDA-MB-231 (ATCC®
HTB-26™) was cultured in Dulbecco’s Modified Eagles
(DMEM)/F-12 medium (Thermo Fisher) supplemented with
10% fetal bovine serum (FBS), 100 IU/mL penicillin, and
100 μg/mL streptomycin in a humidified incubator at 37 °C with
5% CO2. Cells were maintained under 80% confluency and
passaged accordingly using 0.25% Trypsin/EDTA. For generation of α1-PDX stables, cells seeded at a density of 5 × 105 cells/
mL and grown for 24 h were transfected with Alpha1Antitrypsin Portland (α1-PDX, Jean et al. 1998) pRc/CMV vector using Lipofectamine 2000 (Thermo Fisher) according to
manufacturer’s instructions. Following transfection, cells were
split 1:1000 and incubated in DMEM/FBS medium containing
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1 mg/mL neomycin analog G418 (VWR). Individual colonies
were selected after 4 weeks of incubation in selection medium
and expanded to assay for α1-PDX expression by qPCR. The
resulting clonal cells were called 231-PDX.

β-Actin signal. ERK1/2 activation is presented as a ratio between pERK and total ERK1/2 band intensities.

RNA extraction and quantitative real-time PCR

Cells were seeded at a density of 3.0 × 104 cells/mL in a 96well culture plate (Corning) and incubated for 24 h. Following
incubation, cells were transfected with luciferase reporter plasmids using Lipofectamine 2000 (Thermo Fisher), according to
the manufacturer’s instructions. Either 0.2 μg of mammalian
3xAP1pGL3 (Addgene Plasmid #40342) for AP1 transcription, or p1242 3xKB-L (Plasmid #26699) for NF-κB transcription were transfected into cells. 36 h later, cells were
lysed and treated with Firefly Luciferase Glow Assay reagents
(Thermo Fisher) according to the manufacturer’s instructions.
Luminescence was detected using Modulus™ II Microplate
Multimode Reader and the GloMax®- Multi Detection
System with Instinct® Software.

Parental MDA-MB-231 and 231-PDX cells seeded at a density of 1 × 106 cells/mL in DMEM/FBS were grown for 36 h
and subsequently lysed and RNA was collected using the
RNeasy kit (Qiagen). cDNA was synthesized from 1 μg of
RNA using qScript cDNA supermix (Quanta). The relative
mRNA levels of α1-PDX, MT1-MMP, MMP-2, and MMP9 were assayed by qPCR using SensiFAST SYBR No-ROX
Kit (FroggaBio) and the CFX Connect™ Real-Time PCR
Detection System (Bio-Rad). mRNA levels were quantified
by the ΔΔCT method and displayed as fold change relative to
MDA-MB-231 cells. The level of GAPDH mRNA was used
as the internal control. Primers used were as follows:
α1-PDX 5′-TGAAATCCTGGAGGGCCTGA 5′-AACC
AGCCAGACAGCCAGCT.
MT1-MMP 5′-GCAGAAGTTTTACGGCTTGCA 5′TCGAACATTGGCCTTGATCTC.
MMP-2 5′- AGCTCCCGGAAAAGATTGATG 5′-CAGG
GTGCTGGCTGAGTAGAT.
MMP-9 5′-CCTGGAGACCTGAGAACCAATC 5′GATTTCGACTCTCCACGCATCT.
GAPDH 5′-ACCCACTCCTCCACCTTTGA 5′-CTGT
TGCTGTAGCCAAATTCGT.
Protein collection and immunoblotting
Cells were seeded and treated as with qPCR analysis. Cell
lysates were collected and total protein concentration was determined. Protein aliquots (15 μg) were analyzed by immunoblotting with MT1-MMP and β-Actin primary antibodies incubated overnight at 4 °C, followed by incubation with the
appropriate secondary HRP-conjugated antibody for 1 h at
room temperature. Primary antibodies used were: Human
MT1-MMP (1:1000, AB6004, Millipore), pERK (1:2000,
D13.14.4E, Cell Signalling Technology), total ERK1/2
(1:2000, 137F5, Cell Signalling Technology), and β-Actin
(1:1000, C4, Santa Cruz Biotech). Secondary antibodies used
were: goat anti-rabbit IgG (H + L) (Thermo Fisher) and goat
anti-mouse IgG (H + L) (BioRad) HRP conjugates (1:10,000).
Signal was detected using SuperSignal West Pico chemiluminescent substrate (Thermo Fisher). Images were captured using
the Molecular Imager® ChemiDoc™ XRS System (BioRad).
Quantitative densitometric analysis of immunoblots was performed using QuantityOne software (BioRad). Band intensity
was obtained for each of MT1-MMP, β-Actin, pERK and total
ERK1/2 from three independent biological experiments. The
level of MT1-MMP pro- and active protein is normalized to the

Firefly luciferase transcriptional activity assay

Transwell cell motility assays
The migratory and invasive potential of cells was measured
using 24-well 8 μm pore transwell inserts (Corning). Cells
were seeded at a density of 2.0 × 104 cells/mL on the upper
chamber of the transwell insert in serum-free media and
allowed to migrate (24 h) or invade (48 h) towards the bottom
chamber containing DMEM/FBS, which served as the
chemoattractant. Migration assays were performed with uncoated transwell inserts, while invasion assays were performed with transwell inserts coated with 20% Matrigel (BD
Biosciences). Cells that migrated into the bottom chamber
were fixed, stained, and quantified as per Marshall (2011).
Cells were fixed in 100% methanol and cells that did not move
through the transwell were removed with a damp cotton swab.
Fixed cells were stained with 0.5% crystal violet diluted in
distilled water. To quantify cell migration, the stained
transwells were individually de-stained in 33% acetic acid
and the absorbance was read at 490 nm using the Microplate
Reader Model 3550-UV (BioRad) as a correlative measurement of cell number, with the absorbance measure of control
cells set to 100. To quantify cell invasion, residual stain was
removed using a cotton swab and transwells were imaged
using the Leica DM16000 B microscope with Hamamatsu
camera controller (C10600) at 20× magnification. 15 images
were taken per transwell and blindly quantified using ImageJ
software (NIH, Bethesda), with the number of cells in the
control samples being set as 100.
Three-dimensional cell culture
Cells were embedded in 50% Matrigel matrix (BD
Biosciences) and examined for changes in invasive morphological features as described by Cvetković et al. (2014).
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35 mm glass-bottom cell culture dishes (MatTek) were coated
with 50% Matrigel in serum-free medium. Once this layer
solidified, 2.5 × 104 cells/mL seeded in 50% Matrigel in
serum-free medium was placed above the initial layer,
resulting in cells completely suspended in Matrigel. Cell colony morphology was monitored for 5 days using bright-field
microscopy (Leica DM16000 B microscope with Leica
DFC425 camera) at 10X magnification, capturing 50 μm zstack images (2 μm interval) taken at random locations across
the matrix using Leica MMAF software (Metamorph®). To
score cell morphology, several images representing a field of
view at 20X magnification were blindly analyzed using
ImageJ software (NIH, Bethesda). Protrusions were defined
as thin extensions that emanated from a round cell colony. Our
previous work has associated these structures with the actin
cytoskeleton, the presence of MT1-MMP, and increased migration (Cepeda et al. 2016). The number of protrusions on all
cell colonies in an image was counted, with longer protrusions
counted as multiples of the average protrusion length seen in
that image to adjust for the heterogeneity in size observed as
per Cepeda et al. 2016. Disseminations were defined as small,
round cells or particles immediately adjacent to a larger cell
colony. We have shown that many of these particles do not
contain nuclei and that such disseminations are associated
with poor cell health and decreased migration (Cepeda et al.
2016). The score represented the total number of protrusions
or total number of disseminations for each treatment divided
by the total number of colonies, which gave a final measurement of protrusions or disseminations per colony.
Avian embryo tumour vascularization assay
The invasion and vascularization of artificial Matrigel tumours of MDA-MB-231 cells and 231-PDX cells stably expressing ZsGreen were assessed in avian embryos. A superficial wound was introduced to the vasculature of the CAM of
day 9 embryos and an artificial tumour composed of 10 μL of
Matrigel (BD Bioscience) containing 5 × 105 cells was
injected into the wound. 8 days post-implantation, tumours
were examined using fluorescent stereomicroscopy to examine vascularization of the tumour shown by the presence of
non-fluorescent CAM vessels within the zsGreen tumour.
Vascularization was quantified as a binary measurement, indicated by the presence or absence of embryo-derived vasculature in a tumour, while total wound closure was used as a
measure of tumour invasion, characterized by the presence
of the tumour completely under the CAM (as per Cepeda
et al. 2016).
Statistical analysis
GraphPad Prism version 6.0 was used for all statistical analysis and graphing. Data are presented as mean ± SEM, where
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all experiments comprised 3 or more biological replicates.
Paired t-tests, one way ANOVA followed by independentsample t-tests, or chi-squared tests were used as indicated
respectively in each figure legend. The different levels of significance are denoted as follows:
ns, p > 0.1; #, p ≤ 0.1; *, p ≤ 0.05; **, p ≤ 0.01; ***,
p ≤ 0.001; ****, p ≤ 0.0001.

Results
Stable expression of α-PDX in MDA-MB-231 cells did not
result in decreased MT1-MMP protein levels.
The α1-PDX gene contains a conserved R-X-X-R sequence,
which unlike α1-antrypsin, specifically targets the activation
site of furin and inhibits its protein convertase activity (Jean
et al. 1998; Thomas 2002). We generated clonal MDA-MB231 cells (231-PDX) that stably express the α1-PDX gene at
~4 fold increase (Fig. 1a) compared to MDA-MB-231 parental cells. While the MMP-2 mRNA level is downregulated to
0.3 fold, MMP-9 mRNA is upregulated 6 fold in 231-PDX
(Fig. 1c and d). In contrast to chemical inhibition of furin
(Cepeda et al. 2017a), stable expression of α1-PDX in
MDA-MB-231 cells did not decrease MT1-MMP protein
levels. Instead, 231-PDX stable cells contained significantly
higher levels of MT1-MMP mRNA (Fig. 1b). Protein bands
identified as MT1-MMP through the use of a well characterized antibody (Cepeda et al. 2016; Cepeda et al. 2017a,b)
corroborated increased RNA levels by demonstrating increased protein levels (Fig. 2a). While the level of pro-MT1MMP did increase in 231-PDX cells (Fig. 2a and data not
shown), densitometric quantification showed that the percentage of pro-MT1-MMP compared to total MT1-MMP protein
levels did not differ between 231-PDX cells (21%), and
MDA-MB-231 parental cells (21%) (Fig. 2b). Taken together,
these results suggest that stable expression of α1-PDX in
MDA-MB-231 cells increased MT1-MMP, both at the transcript and total protein level, while the percentage of proMT1-MMP protein remained at about 21% of total MT1MMP.
231-PDX stable cells mediated elevated MT1-MMP levels
that were mirrored by MMP-9, and pERK, but not
MMP-2 levels.
We previously showed that following chemical inhibition of
furin, MMP activity, or MAPK signalling in MDA-MB-231
cells, all changed MT1-MMP levels that were mirrored by
MMP-9 and pERK, but opposite to MMP-2 levels (Cepeda
et al. 2017a). In agreement with our previous work, analysis
here revealed that 231-PDX stable cells contained significantly higher levels of MT1-MMP (Fig. 1b) and MMP-9
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Fig. 1 Stable overexpression of
α1-PDX in MDA-MB-231 cells
altered MMP mRNA levels.
qPCR was used to compare a) α1PDX, b) MT1-MMP, c) MMP-2,
and d) MMP-9 mRNA levels in
parental MDA-MB-231 versus
MDA-MB-231 cells stably
transfected with α1-PDX.
GAPDH was used as the internal
control, and data is displayed as
mRNA fold change ± SEM
relative to parental and analyzed
via t-test. ****, p ≤ 0.0001; ***,
p ≤ 0.001

transcripts (Fig. 1d), as well as pERK protein (Fig. 2a,c), but
significantly lower levels of MMP-2 transcripts (Fig. 1c).

transcription (Fig. 3a), whereas they showed a significant decrease in NF-κB transcriptional activity (Fig. 3b).

231-PDX stable cells demonstrated a decrease in NF-κB
transcriptional activity.

231-PDX stable cells exhibited reduced migratory
potential

To investigate possible mechanisms for the observed changes
in MMP-2 and MMP-9 mRNA levels that are mediated by
stable expression of α1-PDX in MDA-MB-231 cells, a luciferase gene reporter assay was conducted. Plasmids encoding
luciferase under the regulation of either AP-1 or NF-κB promoters were transiently transfected into MDA-MB-231 parental cells and 231-PDX cells, and transcription was assayed
after 36 h. Compared to MDA-MB-231 parental cells, 231PDX cells showed a lower, but not significant change in AP-1

Since 231-PDX stable cells displayed altered MT1-MMP,
MMP-2, and MMP-9 transcript levels, and decreased NF-κB
transcriptional activity, we investigated if these changes altered the migratory and invasive potential of these cells. The
migratory potential of 231-PDX cells was examined through
an uncoated transwell insert for 24 h. 231-PDX cells were
significantly less migratory (by 19%) compared to MDAMB-231 parental cells (Fig. 4a). Invasion was measured
through the use of a Matrigel-coated transwell insert for

Fig. 2 Stable overexpression of α1-PDX in MDA-MB-231 cells altered
MT1-MMP and pERK protein levels. a) Representative immunoblot
image of MT1-MMP, control β-actin, and ERK protein levels in
parental MDA-MB-231 versus MDA-MB-231 cells stably transfected
with α1-PDX. Protein band identity was previously demonstrated
(Cepeda et al., 2016). b) Corresponding densitometry quantification of

pro-MT1-MMP amounts normalized to β-actin, and displayed as percent
of total MT1-MMP protein represented by pro-MT1-MMP. c)
Densitometry quantification of pERK normalized to total ERK levels.
Data is displayed ± SEM and analyzed via t-test. ns = not significant; *,
p ≤ 0.05
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Fig. 3 231-PDX cells demonstrated decreased NF-κB transcription.
MDA-MB-231 parental cells and 231-PDX cells were transfected with
either mammalian a) 3xAP-1 or b) 3xNF-κB luciferase reporter plasmids.
Following transfection, luciferase activities were measured. Data is
displayed as mean luminescence (a.u.) ± SEM and analyzed via t-test.
ns = not significant; **, p ≤ 0.01

48 h, where the Matrigel acts as a barrier to simple migration.
231-PDX cells exhibited a slight decrease in invasion (p ≤ 0.1)
compared to MDA-MB-231 parental cells (Fig. 4b).
231-PDX stable cells exhibited morphological changes
in 3D cell culture
In order to determine the effect of altered MT1-MMP activation levels on cell morphology, MDA-MB-231 parental cells
and 231-PDX cells were grown in 50% Matrigel. By day 5,
morphological differences were apparent between the cell
lines where 231-PDX cells exhibited large round clumps of
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cells that lacked the long elongated cell structures seen in the
parental MDA-MB-231 cells (Fig. 5a). We have previously
used Bprotrusions^ as a quantifiable measure of cellular projections to demonstrate that MT1-MMP is associated with
actin (needed for migration), but that with high levels of
MT1-MMP, such actin protrusions decrease. Similarly, high
levels of MT1-MMP are associated with cellular disseminations, many which lack a nucleus, and represent cells that are
less healthy and less invasive (Cepeda et al. 2016; Cepeda
et al. 2017a). Here, 231-PDX cells had significantly less protrusions (~6 per colony) than MDA-MB-231 parental cells
(~9 per colony) (Fig. 5b). Alternatively, 231-PDX cells had
significantly more disseminations per colony compared to
MDA-MB-231 cells (Fig. 5c).
231-PDX stable cells exhibited reduced vascularization
and decreased wound closure within avian CAM
To assess the role of altering levels of MT1-MMP activation
on tumour phenotype, artificial Matrigel tumours composed
of ZsGreen tagged MDA-MB-231 parental cells or 231-PDX
cells were injected into a wound in the CAM vasculature of 9day old avian embryos and incubated for an additional 8 days.
Following incubation, vascularization and wound closure of
the tumour site was observed (Fig. 6a). Vascularization was
determined by the presence of chick vasculature within an
excised tumour (as per Cepeda et al. 2016, and data not
shown). MDA-MB-231 tumours had high incidences of vascularization (19/21) while 231-PDX tumours had lower, but
not significantly different, incidences of vascularization (9/12)
(Fig. 6b). Complete wound closure was defined as when the
tumour was completely covered by chick tissue. MDA-MB231 tumours had a high incidence of wound closure (13/16),
while complete wound closure was significantly lower with
231-PDX tumours (3/8) (Fig. 6c).

Discussion

Fig. 4 Stable overexpression of α1-PDX decreased the migratory ability of
MDA-MB-231 cells. MDA-MB-231 parental cells and 231-PDX cells were
plated on the upper surface of an a) uncoated transwell insert (migration) or
b) an insert coated with 20% Matrigel (invasion), and incubated in serumfree medium for 24 h (migration) and 48 h (invasion), respectively. Number
of migrated/invaded cells was normalized to MDA-MB-231 parental cells
and expressed as a mean percentage ± SEM. Data was analyzed via t-test;
****, p ≤ 0.0001; #, p ≤ 0.1

We sought to elucidate the effects of stable α1-PDX overexpression on MT1-MMP levels and resulting cell behaviour in
MDA-MB-231 cells. MT1-MMP has garnered much attention, in part due to its capability to increase the migratory
capacity of cells through its ability to remodel the ECM, cell
surface molecules, and facilitate signalling cascades
(D'Alessio et al. 2008; Gingras et al. 2001; Mori et al. 2002;
Rozanov et al. 2001; Zarrabi et al. 2011). These wide-ranging
functions are reflected by the complexities of MT1-MMP regulation: transcriptionally, by JNK, Akt, ERK1/2, and NF-κB
(Han et al. 2001; Li et al. 2016; Yoshimoto et al. 2014;); posttranscriptionally by MT1-MMP micro-RNAs, such as miR133a and miR-150-5p (Sakr et al. 2016); and posttranslationally, as pro-MT1-MMP needs to be activated.
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Fig. 5 Stable overexpression of
α1-PDX in MDA-MB-231 cells
inhibited a protrusive phenotype
in Matrigel 3D culture. a) Bright
field images of MDA-MB-231
parental cells and 231-PDX cells
1, 3, and 5 days after being
embedded in Matrigel. Scale
bars = 100 μm. The number of
protrusions b) or disseminations
c) per colony for each treatment
was blindly quantified every day
for 5 days during 3D culture.
Means are presented ± SEM, and
were compared using one-way
ANOVA; with statistical
differences seen as follows: for
protrusions; days 2 and 5,
p ≤ 0.01; days 3 and 4, p ≤ 0.0001;
disseminations: days 2–4,
p ≤ 0.05; day 5, p ≤ 0.01

Furin has long been known to be important in regulating the
level of active MT1-MMP (Coppola et al. 2008; Jean et al.,
1998; Rozanov et al. 2001). However, furin seems to only
partially contribute to the activation of pro-MT1-MMP (Jean
et al. 1998; Otto et al., 2016), and other players working in
concert with furin may also be necessary, including the nonreceptor tyrosine kinase c-Src (Shi et al. 2012), Golgi adapter
protein GRASP55 (Roghi et al., 2010), and even
mechanosensitive stress events (Kang et al. 2015).
Using MCF-7 cells (which natively lack MT1-MMP), we
have shown that non-physiologically high levels of MT1MMP protein (that result following transient transfection)
may not be functionally meaningful. By creating stable cell
lines, we demonstrated that a moderate (10 fold) increase in
MT1-MMP levels was most potent with respect to changes in
pERK signaling, cell survival, and cell migration and invasion
(Cepeda et al. 2016). We observed a consistent pattern when
these stable cells, or MDA-MB-231 cells (which naturally
express MT1-MMP), were treated with inhibitors to furin,
MMP activity, and MAPK signalling: high levels of active
MT1-MMP, pERK, and MMP-9, but low levels of MMP-2
(Cepeda et al. 2016; Cepeda et al. 2017a).
Here we created MDA-MB-231 cells that stably express
moderate levels of α1-PDX. This stable expression of α1PDX resulted in increased expression of MT1-MMP and

MMP-9, but decreased MMP-2 mRNA, and increased
levels of pERK (Fig. 1 and 2), in a pattern identical to that
seen in our MCF-7 cells treated with inhibitors that impinge on MT1-MMP function (Cepeda et al. 2017a). As
MT1-MMP can facilitate signalling through the MAPK
pathway, elevation of MT1-MMP levels followed by increased levels of pERK is not surprising. However, the
consistent pattern of increased MMP-9, but decreased
MMP-2 mRNA, is intriguing.
Through the inhibition of furin, α1-PDX should result in a
decrease in the level of active MT1-MMP protein, and perhaps a proportional increase in pro-MT1-MMP. However, in
our study, stable α1-PDX expression increased both MT1MMP transcripts as well as total protein levels (Fig. 1b, 2a,
and data not shown). This MT1-MMP increase following
furin inhibition or α1-PDX overexpression has been demonstrated previously (Bassi et al. 2001; Yana and Weiss 2000).
Cells have an innate required level of MT1-MMP – with different cell types having different levels depending on their
functions. This level of MT1-MMP is part of a native network
with pERK, MMP-2, MMP-9, and likely other players, that
are all modulated in tandem in a particular cell type. Here,
with α1-PDX, while overall MT1-MMP protein levels did
increase, it is interesting to note that the percentage of total
MT1-MMP protein represented by pro-MT1-MMP did not
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Fig. 6 Stable overexpression of α1-PDX in MDA-MB-231 cells resulted
in fewer incidences of vascularization and wound closure within avian
CAM. MDA-MB-231 parental and 231-PDX cells that stably express a
ZsGreen marker were combined with Matrigel and injected into a wound
made in the vasculature of the CAM of a 9-day old avian embryo (and
assayed as per Cepeda et al. 2016). Eight days post wound generation,
bright field and fluorescence stereomicroscopy were used to examine the
tumour site. Vascularization was assessed by identifying novel capillaries
within the tumour. Wound closure was assessed by closure of scar tissue
and the resultant lack of tumour above the CAM. a) Representative bright

field and fluorescence microscopy images of tumours beneath CAM with
MDA-MB-231 cells (top panels) and 231-PDX cells (bottom panels).
Scale bars = 2 mm. b) Multiple embryos and tumour sites assessed for
vascularization (33) and c) completeness of wound closure (24). The
relationship between cell line and vascularization was compared using a
chi-squared test of independence; X2 (1, N = 33) = 2.494, p = 0.114. The
relationship between cell line and wound closure was compared using a
chi-squared test of independence, and was statistically different; X2 (1,
N = 24) = 5.513, p = 0.019

change – remaining at about 21% (Fig. 2b) Despite the expression of α1-PDX and its expected effect to increase the
level of pro-MT1-MMP, the cells compensate by increasing
overall MT1-MMP levels to maintain the pro-MT1-MMP
levels at 21%. A similar mechanism, though likely at a different threshold level, may also explain the increase of MT1MMP levels seen in other cell types (head and neck squamous
carcinomas, COS-1, HT-1080, and LoVo cells; Yana and
Weiss 2000; Bassi et al. 2001) treated with α1-PDX.

Altering MT1-MMP function can be associated with altered cell movement. But this relationship is cell type specific.
We, and others, have demonstrated that MT1-MMP can modulate pERK levels. In our previous work with MCF-7 cells,
optimal (moderate) levels of active MT1-MMP result in high
pERK levels and high cell migration that is mitigated by
pERK inhibition (Cepeda et al. 2016). Here, however, elevated MT1-MMP and elevated pERK levels resulted in reduced
migration. This is perhaps because unlike MCF-7 cells, where

Stable expression of α1-antitrypsin Portland in MDA-MB-231 cells increased MT1-MMP and...

increased MT1-MMP levels resulted in increased levels of
transcription by NF-κB (Cepeda et al. 2017b), here MDAMB-231 cells with increased MT1-MMP levels resulted in
decreased levels of transcription by NF-κB (Fig. 3). While
the mechanism is not known, there are reports of direct
MT1-MMP modulation of NF-kB signalling through PI3Kδ
signalling (Wong et al. 2016), and several studies have demonstrated an indirect link between NF-kB and MT1-MMP
levels and cell migration (Kwiatkowska et al. 2011; Takino
et al. 2016).
We have also previously reported (Cepeda et al. 2016) that
while high levels of MT1-MMP protein were associated with
high levels of ECM degradation, this did not manifest in high
levels of cell movement, nor invasion. Indeed, increasing
MMP enzymatic activity did not impact cell movement as
much as treatments that altered MT1-MMP induced pERK
levels, such as the use of TIMP-2 as a ligand (Cepeda et al.
2016; Cepeda et al. 2017a). Additionally, high levels of MT1MMP altered cellular morphologies (reduced protrusions) and
increased a-nuclear cell disseminations, as high levels of
MT1-MMP were associated with poor cell survival (Cepeda
et al. 2016; Cepeda et al. 2017a). Here we demonstrate that
elevated levels of MT1-MMP and MMP-9 following α1-PDX
treatment reduced both cell migration and cell invasion (Fig.
4). In addition, these elevated MT1-MMP and MMP-9 levels
resulted in cellular morphologies not conducive to movement.
When examined in 3D culture, 231-PDX cells contained fewer membrane extensions that are fundamental to cell movement, while also fragmenting (Fig. 5). These in vitro cell
movement limitations were corroborated in vivo using a chick
CAM assay. When parental MDA-MD-231 cells were placed
in a wound on the chick CAM, this resulted in the recruitment
of vasculature into the tumour, as well as movement of the
tumour into the chick tissue, such that there is complete
wound closure (Fig. 6). Parental MDA-MB-231 cells had very
high degrees of vascularization (19/21) and wound closure
(13/16). The 231-PDX cells had a reduced, but not significantly lower, frequency of vascularization (9/12), and a significantly lower frequency of wound closure (3/8). Changes in
vascularization and wound closure require both ECM remodelling activity as well as changes in cell morphology and migration. Such coordination of ECM remodelling and cell morphology can be coordinated by MT1-MMP. As expression of
α1-PDX should inhibit pro-MT1-MMP activation, a decrease
in such cell movement events is perhaps not surprising.
However, it should be noted that decreases in tumour progression may not necessarily be directly related to decreased levels
of active MT1-MMP. Previously we saw that altering MT1MMP levels via MMP inhibition (BB-94), MT1-MMP activation (furin inhibitor), or pERK signalling (U0126) all resulted in the same pattern – levels of MT1-MMP, MMP-9 and
pERK always together, and opposite to that of MMP-2
(Cepeda et al. 2016; Cepeda et al. 2017b). Thus, it is not the
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absolute level of MT1-MMP (indeed of any MMP) that is
predictive of the invasive or migratory potential of a cell, but
it is the coordinated actions of several factors that work in
concert to impact numerous aspects of cellular function.
This work highlights the conservation of the network of
molecules through which MT1-MMP functions, particularly
its association with pERK, MMP-9, and MMP-2, and also
reveals differences between cell types when MT1-MMP function is altered, as these cells try to maintain innate MT1-MMP
protein networks and related signalling pathways.
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